Key result
Multimodal imaging and R-miniCHOP achieve 65-month progression-free survival in a primary cardiac lymphoma patient.
Why the study?
Primary cardiac lymphoma is an extremely rare malignancy.
Population
A 76-year-old woman with chest tightness, exertional dyspnea, and nocturnal orthopnea
Design
Case report
Follow-up
65 months
Authors
Loading...
Multimodal imaging may aid primary cardiac lymphoma evaluation; leaves open broader outcome impact pending prospective data.
Case Report (n=1)
No
Multimodal imaging provides crucial complementary information for the comprehensive evaluation, diagnosis, and treatment monitoring of primary cardiac lymphoma.
Shi et al. (2026) conducted a case report in Primary cardiac lymphoma (diffuse large B-cell lymphoma) (n=1). Multimodal imaging and R-miniCHOP chemotherapy was evaluated on Complete remission and progression-free survival. Multimodal imaging combined with 5 cycles of R-miniCHOP chemotherapy led to complete remission and 65 months of progression-free survival in a 76-year-old woman with primary cardiac lymphoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: